Omega-3 Questions Could Pull Plug On Sales Growth

Pharma firms’ introduction and wide promotion of Rx drugs containing EPA or DHA acids and aimed at improving cardiovascular health were expected to boost omega-3 supplement sales, but negative research results reported over the past year could diminish consumers’ regard for the nutrients’ benefits.

Increasing debate around the health benefits of fish oils could damage consumer regard for omega-3 supplements, a product category with strong sales growth despite being restricted to qualified health claims in the U.S.

Omega-3 supplement sales were expected to get a boost from pharma firms’ introduction and wide promotion of Rx drugs containing...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America